Biodesix Inc SEC filings BDSX
Biodesix Inc has 600 filings in SEC EDGAR's recent list, going back to Jul 8, 2008. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 29, 2026 | — |
| CORRESP | Letter to the SEC | May 27, 2026 | — |
| UPLOAD | Letter from the SEC | May 26, 2026 | — |
| EFFECT | Filing | Nov 12, 2024 | — |
| EFFECT | Filing | Nov 12, 2024 | — |
| CORRESP | Letter to the SEC | Nov 7, 2024 | — |
| CORRESP | Letter to the SEC | Nov 7, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 6, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 6, 2024 | — |
| EFFECT | Filing | Jun 4, 2024 | — |
| CORRESP | Letter to the SEC | May 31, 2024 | — |
| CORRESP | Letter to the SEC | May 24, 2024 | — |
| UPLOAD | Letter from the SEC | May 17, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 30, 2024 | — |
| SC TO-I/A | Filing | Jul 26, 2023 | — |
| SC TO-I/A | Filing | Jul 3, 2023 | — |
| CORRESP | Letter to the SEC | Jul 3, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 28, 2023 | — |
| SC TO-I | Filing | Jun 23, 2023 | — |
| EFFECT | Filing | Jun 17, 2022 | — |
| CORRESP | Letter to the SEC | Jun 15, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2022 | — |
| EFFECT | Filing | Nov 29, 2021 | — |
| CORRESP | Letter to the SEC | Nov 24, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 22, 2021 | — |
| SEC STAFF LETTER | Filing | Oct 27, 2020 | — |
| EFFECT | Filing | Oct 27, 2020 | — |
| CERT | Filing | Oct 26, 2020 | — |
| 8-A12B | Filing | Oct 26, 2020 | — |
| CORRESP | Letter to the SEC | Oct 23, 2020 | — |
| CORRESP | Letter to the SEC | Oct 23, 2020 | — |
| CORRESP | Letter to the SEC | Oct 23, 2020 | — |
| CORRESP | Letter to the SEC | Oct 19, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 19, 2020 | — |
| CORRESP | Letter to the SEC | Oct 16, 2020 | — |
| CORRESP | Letter to the SEC | Oct 13, 2020 | — |
| SEC STAFF LETTER | Filing | Oct 9, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 9, 2020 | — |
| D/A | Filing | Oct 1, 2020 | — |
| DRS/A | Filing | Sep 22, 2020 | — |
| DRSLTR | Filing | Sep 21, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2020 | — |
| DRS | Filing | Aug 12, 2020 | — |
| D | Filing | Dec 20, 2019 | — |
| D | Filing | Aug 22, 2019 | — |
| D | Filing | Oct 23, 2018 | — |
| D/A | Filing | Jul 18, 2018 | — |
| D | Filing | Jul 16, 2018 | — |
| D | Filing | May 8, 2018 | — |
| D | Filing | Mar 9, 2018 | — |
| D | Filing | Apr 24, 2017 | — |
| D | Filing | Nov 30, 2016 | — |
| D | Filing | Jul 27, 2016 | — |
| D | Filing | Feb 12, 2016 | — |
| D | Filing | Oct 8, 2015 | — |
| D | Filing | Jun 23, 2015 | — |
| D | Filing | Jan 13, 2015 | — |
| D/A | Filing | Jan 13, 2014 | — |
| D | Filing | Dec 3, 2013 | — |
| D | Filing | Oct 22, 2013 | — |
| D | Filing | Apr 11, 2013 | — |
| D | Filing | Sep 4, 2012 | — |
| D | Filing | Jul 5, 2011 | — |
| D | Filing | Oct 28, 2010 | — |
| D/A | Filing | Oct 23, 2009 | — |
| D | Filing | Sep 28, 2009 | — |
| REGDEX | Auto-generated paper document | Sep 2, 2008 | — |
| REGDEX | Auto-generated paper document | Sep 2, 2008 | — |
| REGDEX | Auto-generated paper document | Sep 2, 2008 | — |
| REGDEX | Auto-generated paper document | Sep 2, 2008 | — |
| REGDEX | Auto-generated paper document | Sep 2, 2008 | — |
| REGDEX | Auto-generated paper document | Jul 8, 2008 | — |
Showing 72 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- BDSX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Louisville, CO
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1439725
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.